---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
---

## ðŸ“„ Manuscripts In Submission *(# co-first author)*

- Huang, L.#, Liu P.P.#, Du, Y.#, Pan, D.N., Chen, Q.B., Wang, Y.X.  
  *A novel adipokine suppresses leptin signaling and food intake.*  
  **Nature Metabolism**, *In revision* (UMass Medical School)

---

## ðŸ§« Publications in Microbiology and Immunology

- Du Y#, Faz-Lopez B#, Ah Kioon MD, Cenac C, Pierides M, Lakin K, Spiera RF, Chaumeil J, Truchetet ME, Gordon JK, GuÃ©ry JC*, Barrat FJ* (2025).  
  *Altered X-chromosome inactivation of the TLR7/8 locus and heterogeneity of plasmacytoid DCs in systemic sclerosis.*  
  **J Exp Med**, 222(3): e20231809.

- Du, Y., Ah Kioon, M.D., Laurent, P., et al. (2022).  
  *Chemokines form nanoparticles with DNA and can superinduce TLR-driven immune inflammation.*  
  **J Exp Med**, 219(7): e20212142.

- Xiao X#, Du Y#, Sun S, et al. (2024).  
  *Apex1 safeguards genomic stability to ensure a cytopathic T cell fate in autoimmune disease models.*  
  **J Clin Invest**, 135, 10.1172/JCI183671.

- Wang J.Y.#, Lu W.T.#, Zhang J.#, Du Y.#, et al. (2024).  
  *Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress and ROS responses in male mice.*  
  **Nat Commun**, 15:3481.

- Ah Kioon, M.D.#, Laurent, P.#, Chaudhary, V.#, Du, Y.#, et al. (2024).  
  *Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity.*  
  **Immunol Rev**

- Xiong, D.#, Du, Y.#, et al. (2015).  
  *Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells.*  
  **PNAS**, 112:11036-11041. *(Ph.D. thesis)*

- Chaudhary, V., Mishra B, Ah Kioon, M.D., Du, Y., Barrat F.  
  *Regulation of NRF2 in plasmacytoid DCs determines resolution versus fibrosis in the skin.*  
  **J Exp Med**, *Accepted.*

- Cakan, E., Ah Kioon, M.D., Du, Y., et al. (2023).  
  *TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance.*  
  **J Exp Med**, 220.

- Yang, C., Bachu, M., Du, Y., et al. (2022).  
  *CXCL4 synergizes with TLR8 for TBK1-IRF5 activation, epigenomic remodeling and inflammatory response in human monocytes.*  
  **Nat Commun**, 13, 3426.

- Xia, Y., Inoue, K., Du, Y., et al. (2022).  
  *TGFÎ² reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis.*  
  **Nat Commun**, 13, 3920.

- Xing, J., Zhang, A., Du, Y., et al. (2021).  
  *PARP9 as a noncanonical sensor for RNA virus in dendritic cells.*  
  **Nat Commun**, 12, 2681.

- Zhang, A., Xing, J., Du, Y., et al. (2020).  
  *EphA2 phosphorylates NLRP3 and inhibits inflammasomes in airway epithelial cells.*  
  **EMBO Rep**, 21: e49666.

- Zhang, H., Li, Y., Du, Y., et al. (2018).  
  *Ephrin receptor A2 is an epithelial receptor for Epstein-Barr virus entry.*  
  **Nat Microbiol**, 3:1â€“8.

- Ni, C., Chen, Y., Du, Y., et al. (2015).  
  *In-cell infection: a novel pathway for EBV infection via cell-in-cell structures.*  
  **Cell Res**, 25:785â€“800.

- Wang, H.B., Zhang, H., Du, Y., et al. (2015).  
  *Neuropilin 1 promotes EBV infection of nasopharyngeal epithelial cells.*  
  **Nat Commun**, 6:6240.

---

## ðŸ§¬ Publications in Cancer Biology

- Du, Y.#, Liu, L.#, Wang, C.#, et al. (2016).  
  *TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis.*  
  **Oncotarget**, 7:41885â€“41897.

- Du, Y.#, Yan, S.M.#, Gu, W.Y., et al. (2015).  
  *FADS1 predicts poor prognosis in esophageal squamous cell carcinoma.*  
  **APJCP**, 16:5089â€“5094.

- Dai, D.N.#, Li, Y.#, Chen, B.#, Du, Y.#, et al. (2017).  
  *CST1 promotes breast cancer progression and poor prognosis.*  
  **J Mol Med**, 95:873â€“886.

- Yuan, Y.#, Du, Y.#, et al. (2017).  
  *Longikaurin A suppresses stemness in nasopharyngeal carcinoma.*  
  **Oncol Lett**, 13:1672â€“1680.

- Chen, R.H.#, Du, Y.#, et al. (2016).  
  *ISG15 promotes cancer stem cell phenotype in nasopharyngeal carcinoma.*  
  **Oncotarget**, 7:16910â€“16922.

- Li, R.C.#, Du, Y.#, et al. (2016).  
  *EBV gp42 antibody for nasopharyngeal carcinoma diagnosis.*  
  **Clin Lab**, 62:553â€“561.

- Li, R.C.#, Du, Y.#, et al. (2016).  
  *EBV gH/gL antibodies complement IgA-VCA in NPC diagnosis.*  
  **Oncotarget**, 7:16372â€“16383.

---

## ðŸ“‘ Patent

- Wang, Y.X., Huang, L., Du, Y. (2019).  
  *Methods for improving leptin sensitivity for the treatment of obesity and diabetes.*  
  **WO/2019/21770**
